Research Alliance Corp IV Completes IPO, $75M Deposited in Trust

What Happened
Research Alliance Corporation IV announced on July 14, 2026 that it consummated its initial public offering (IPO) of 7,500,000 Class A ordinary shares at $10.00 per share and completed a simultaneous private placement of 275,000 Class A ordinary shares to its sponsor. Gross proceeds were $75,000,000 from the IPO and $2,750,000 from the private placement. As of July 14, 2026, $75,000,000 of the net proceeds (including the underwriter’s deferred commission of $2,250,000) were deposited in a trust account for the benefit of the Company’s public shareholders; Continental Stock Transfer & Trust Company is the trustee. An audited balance sheet as of July 14, 2026 reflecting these receipts is filed as Exhibit 99.1.

Key Details

• IPO: 7,500,000 Class A ordinary shares sold at $10.00 per share; gross proceeds $75,000,000.
• Private Placement: 275,000 Class A shares sold to Research Alliance Holdings IV LLC at $10.00 each; gross proceeds $2,750,000.
• Trust deposit: $75,000,000 of net proceeds (including a $2,250,000 deferred underwriting commission) deposited in a trustee-held trust on July 14, 2026.
• Trustee: Continental Stock Transfer & Trust Company; audited balance sheet included as Exhibit 99.1.

Why It Matters
Completion of the IPO and the sponsor’s private purchase provide cash and establish the typical SPAC structure where public offering proceeds are held in trust for public shareholders until a business combination. The $75M in trust is the primary pool of capital for pursuing a target; having an audited balance sheet and a trustee in place is a routine but important step for investor protection. The filing does not report operating results or management changes.